GH Research PLC (GHRS)
11.68
+0.49
(+4.38%)
USD |
NASDAQ |
May 03, 16:00
11.73
+0.05
(+0.43%)
After-Hours: 20:00
GH Research Total Assets (Quarterly): 226.30M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 226.30M |
| September 30, 2023 | 232.57M |
| June 30, 2023 | 240.27M |
| March 31, 2023 | 249.26M |
| December 31, 2022 | 254.36M |
| September 30, 2022 | 260.12M |
| June 30, 2022 | 266.32M |
| Date | Value |
|---|---|
| March 31, 2022 | 273.54M |
| December 31, 2021 | 279.92M |
| September 30, 2021 | 285.63M |
| June 30, 2021 | 292.82M |
| March 31, 2021 | 5.556M |
| December 31, 2020 | 5.912M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.556M
Minimum
Mar 2021
292.82M
Maximum
Jun 2021
220.97M
Average
254.36M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Amarin Corp PLC | 831.68M |
| Jazz Pharmaceuticals PLC | 11.33B |
| Prothena Corp PLC | 696.38M |
| Iterum Therapeutics PLC | 26.26M |
| Mural Oncology PLC | 301.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.332M |
| Shareholders Equity (Quarterly) | 218.97M |